<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39094497</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-3171</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Poultry science</Title><ISOAbbreviation>Poult Sci</ISOAbbreviation></Journal><ArticleTitle>Development of the first officially licensed live attenuated duck hepatitis A virus type 3 vaccine strain HB80 in China and its protective efficacy against DHAV-3 infection in ducks.</ArticleTitle><Pagination><StartPage>104087</StartPage><MedlinePgn>104087</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">104087</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.psj.2024.104087</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0032-5791(24)00666-7</ELocationID><Abstract><AbstractText>Duck hepatitis A virus type 3 (DHAV-3) is an infectious virus that is highly fatal to ducklings and causes significant economic losses in the duck industry worldwide. Biosecurity and vaccination are required to control the pathogen. In the present study, we attenuated a lowly pathogenic DHAV-3 clinical isolate, named as HB, by serial passaging in duck embryos, and followed by several adaptive proliferations in specific-pathogen-free (SPF) chicken embryos. The virulence of DHAV-3 at different passages was assessed by infecting 3-day-old ducklings. We found that the HB strain lost pathogenicity to ducklings from the 55th passage onwards. The 80th passage strain (HB80), which achieved good growth capacity in duck embryos with a viral titer of 10<sup>8.17</sup> 50% egg lethal dose per milliliter (ELD<sub>50</sub>/mL), was selected as a live attenuated vaccine candidate. The HB80 strain did not induce clinical symptoms or pathological lesions in 3-day-old ducklings and showed no virulence reversion after 5 rounds of in vivo back-passage. The minimum effective dose of HB80 was determined to be 10<sup>4.5</sup> ELD<sub>50</sub> by hypodermic inoculation of the neck. Importantly, a single dose of HB80 elicited good immune responses and provided complete protection against challenge with the lethal DHAV-3 strain. Compared with the genomic sequence of the parental HB strain, HB80 had 7 amino acid substitutions, two of them are in the hypervariable region of the VP1 and polymerase-encoding 3D regions, which may play a role in virulence attenuation. Our data suggest that the attenuated HB80 strain is a promising vaccine candidate for the prevention of DHAV-3 infections in China. HB80 has been registered as a New Veterinary Drug Registration Certificate by the Chinese Ministry of Agriculture and Rural Affairs (MARA), and is the first live attenuated DHAV-3 vaccine strain to be officially licensed in China.</AbstractText><CopyrightInformation>Copyright Â© 2024. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Qiuling</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute of Animal Husbandry and Veterinary Medicine/Fujian Industry Technology Innovation Research Academy of Livestock and Poultry Diseases Prevention and Control, Fujian Academy of Agricultural Sciences/Fujian Key Laboratory for Control and Prevention of Avian Diseases, Fuzhou 350013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Xiangmin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Shanghai Chuanghong Biotech Co., Ltd, Shanghai 201619, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sinopharm Animal Health Corporation Ltd., Wuhan 430075, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiao</LastName><ForeName>Wenlong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Animal Husbandry and Veterinary Medicine/Fujian Industry Technology Innovation Research Academy of Livestock and Poultry Diseases Prevention and Control, Fujian Academy of Agricultural Sciences/Fujian Key Laboratory for Control and Prevention of Avian Diseases, Fuzhou 350013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Rongchang</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Animal Husbandry and Veterinary Medicine/Fujian Industry Technology Innovation Research Academy of Livestock and Poultry Diseases Prevention and Control, Fujian Academy of Agricultural Sciences/Fujian Key Laboratory for Control and Prevention of Avian Diseases, Fuzhou 350013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Zhao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Sinopharm Animal Health Corporation Ltd., Wuhan 430075, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yaping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Chemical and Biological Engineering, Minjiang Teachers College, Fuzhou 350108, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Animal Husbandry and Veterinary Medicine/Fujian Industry Technology Innovation Research Academy of Livestock and Poultry Diseases Prevention and Control, Fujian Academy of Agricultural Sciences/Fujian Key Laboratory for Control and Prevention of Avian Diseases, Fuzhou 350013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Chunhe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Animal Husbandry and Veterinary Medicine/Fujian Industry Technology Innovation Research Academy of Livestock and Poultry Diseases Prevention and Control, Fujian Academy of Agricultural Sciences/Fujian Key Laboratory for Control and Prevention of Avian Diseases, Fuzhou 350013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Shanghai Chuanghong Biotech Co., Ltd, Shanghai 201619, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Qizhang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute of Animal Husbandry and Veterinary Medicine/Fujian Industry Technology Innovation Research Academy of Livestock and Poultry Diseases Prevention and Control, Fujian Academy of Agricultural Sciences/Fujian Key Laboratory for Control and Prevention of Avian Diseases, Fuzhou 350013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Shaohua</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Animal Husbandry and Veterinary Medicine/Fujian Industry Technology Innovation Research Academy of Livestock and Poultry Diseases Prevention and Control, Fujian Academy of Agricultural Sciences/Fujian Key Laboratory for Control and Prevention of Avian Diseases, Fuzhou 350013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Longfei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Animal Husbandry and Veterinary Medicine/Fujian Industry Technology Innovation Research Academy of Livestock and Poultry Diseases Prevention and Control, Fujian Academy of Agricultural Sciences/Fujian Key Laboratory for Control and Prevention of Avian Diseases, Fuzhou 350013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hongmei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Animal Husbandry and Veterinary Medicine/Fujian Industry Technology Innovation Research Academy of Livestock and Poultry Diseases Prevention and Control, Fujian Academy of Agricultural Sciences/Fujian Key Laboratory for Control and Prevention of Avian Diseases, Fuzhou 350013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Nansong</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Animal Husbandry and Veterinary Medicine/Fujian Industry Technology Innovation Research Academy of Livestock and Poultry Diseases Prevention and Control, Fujian Academy of Agricultural Sciences/Fujian Key Laboratory for Control and Prevention of Avian Diseases, Fuzhou 350013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Jingliang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine of China Agricultural University, Beijing 100193, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Guanghua</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Animal Husbandry and Veterinary Medicine/Fujian Industry Technology Innovation Research Academy of Livestock and Poultry Diseases Prevention and Control, Fujian Academy of Agricultural Sciences/Fujian Key Laboratory for Control and Prevention of Avian Diseases, Fuzhou 350013, China. Electronic address: fuyuan163@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Animal Husbandry and Veterinary Medicine/Fujian Industry Technology Innovation Research Academy of Livestock and Poultry Diseases Prevention and Control, Fujian Academy of Agricultural Sciences/Fujian Key Laboratory for Control and Prevention of Avian Diseases, Fuzhou 350013, China. Electronic address: huangyu_815@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Poult Sci</MedlineTA><NlmUniqueID>0401150</NlmUniqueID><ISSNLinking>0032-5791</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014613">Vaccines, Attenuated</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004372" MajorTopicYN="Y">Ducks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014613" MajorTopicYN="Y">Vaccines, Attenuated</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011201" MajorTopicYN="Y">Poultry Diseases</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="Y">Picornaviridae Infections</DescriptorName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="Y">Viral Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013047" MajorTopicYN="N">Specific Pathogen-Free Organisms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004371" MajorTopicYN="N">Hepatitis Virus, Duck</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">duck hepatitis A virus type 3 (DHAV-3)</Keyword><Keyword MajorTopicYN="N">genome analysis</Keyword><Keyword MajorTopicYN="N">live attenuated vaccine candidate</Keyword><Keyword MajorTopicYN="N">protective efficacy</Keyword></KeywordList><CoiStatement>DISCLOSURES The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>21</Day><Hour>21</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>3</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>2</Day><Hour>18</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39094497</ArticleId><ArticleId IdType="pmc">PMC11345565</ArticleId><ArticleId IdType="doi">10.1016/j.psj.2024.104087</ArticleId><ArticleId IdType="pii">S0032-5791(24)00666-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ao D., Sun S.Q., Guo H.C. Topology and biological function of enterovirus non-structural protein 2B as a member of the viroporin family. Vet Res. 2014;45:87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4155101</ArticleId><ArticleId IdType="pubmed">25163654</ArticleId></ArticleIdList></Reference><Reference><Citation>Crighton G.W., Woolcock P.R. Active immunisation of ducklings against duck virus hepatitis. Vet Rec. 1978;102:358â361.</Citation><ArticleIdList><ArticleId IdType="pubmed">207008</ArticleId></ArticleIdList></Reference><Reference><Citation>Danielle M., Ruediger Y., Hauck H.L., Shivaprasad X.J.M. Hepatitis virus infections in poultry. Avian Dis. 2016;60:576â588.</Citation><ArticleIdList><ArticleId IdType="pubmed">27610716</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding C.Y., Zhang D.B. Molecular analysis of duck hepatitis virus type 1. Virology. 2007;361:9â17.</Citation><ArticleIdList><ArticleId IdType="pubmed">17300822</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding D.B., Zhao H.N., Liu Y., Li S.F., Wei J., Yang Y., Wang S.Q., Xing G.N., Hou S.S., Wang X., Zhang Y.S. Whole-transcriptome sequencing revealed the role of noncoding RNAs in susceptibility and resistance of Pekin ducks to DHAV-3. Poult Sci. 2024;103</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10846394</ArticleId><ArticleId IdType="pubmed">38301494</ArticleId></ArticleIdList></Reference><Reference><Citation>Doan H.T., Le X.T., Do R.T., Hoang C.T., Nguyen K.T., Le T.H. Molecular genotyping of duck hepatitis A viruses (DHAV) in Vietnam. J Infect Dev Ctries. 2016;10:988â995.</Citation><ArticleIdList><ArticleId IdType="pubmed">27694732</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenhaber B., Eisenhaber F. Prediction of posttranslational modification of proteins from their amino acid sequence. Methods Mol Biol. 2010;609:365â384.</Citation><ArticleIdList><ArticleId IdType="pubmed">20221930</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakubiec A., Jupin I. Regulation of positive-strand RNA virus replication: the emerging role of phosphorylation. Virus Res. 2007;129:73â79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7132427</ArticleId><ArticleId IdType="pubmed">17764774</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine P.P., Fabricant J. A hitherto-undescribed virus disease of ducks in North America. Cornell Vet. 1950;1:71â86.</Citation></Reference><Reference><Citation>Li G.X., Gao X.Y.X., Liu S.Q., Peng S., Li X.S., Shi Y., Zhang Y., Yu L., Wu X.G., Yan P.X., Yan L.P., Teng Q.Y., Tong G.Z., Li Z.J. Development of a live attenuated vaccine candidate against duck Tembusu viral disease. Virology. 2014;450-451:233â242.</Citation><ArticleIdList><ArticleId IdType="pubmed">24503086</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S.L., Cong R.C., Zhang R.H., Chen J.H., Xia L.L., Xie Z.J., Wang Y., Zhu Y.L., Jiang S.J. Circulation and in vivo distribution of duck hepatitis A virus types 1 and 3 in infected ducklings. Arch Virol. 2016;161:405â416.</Citation><ArticleIdList><ArticleId IdType="pubmed">26597185</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Wang X.W., Mao R.Q., Zhou Y.H., Yin J.B., Sun Y.F., Yin X.P. Research progress on live attenuated vaccine against African swine fever virus. Microb Pathog. 2021;158</Citation><ArticleIdList><ArticleId IdType="pubmed">34089790</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R.C., Shi S.H., Huang Y., Chen Z., Chen C.T., Cheng L.F., Fu G.H., Chen H.M., Wan C.H., Fu Q.L. Comparative pathogenicity of different subtypes of duck hepatitis A virus in Pekin ducklings. Vet Microbiol. 2019;228:181â187.</Citation><ArticleIdList><ArticleId IdType="pubmed">30593365</ArticleId></ArticleIdList></Reference><Reference><Citation>Geourjon C., DelÃ©age G. SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Comput Appl Biosci. 1995;11:681â684.</Citation><ArticleIdList><ArticleId IdType="pubmed">8808585</ArticleId></ArticleIdList></Reference><Reference><Citation>Gough R.E., Borland E.D., Keymer I.F., Stuart J.C. An outbreak of duck hepatitis type II in commercial ducks. Avian Pathol. 1985;14:227â236.</Citation><ArticleIdList><ArticleId IdType="pubmed">18766915</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan T.I.R., Eid A.A.M., Ghanem I.A.I., Shahin A.M., Adael S.A.A., Mohamed F.F. First report of duck hepatitis A virus 3 from duckling flocks of Egypt. Avian Dis. 2020;64:269â276.</Citation><ArticleIdList><ArticleId IdType="pubmed">33205161</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.W., Wang Y.F., Yu C.K., Su I.J., Wang J.R. Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement. Virology. 2012;422:132â143.</Citation><ArticleIdList><ArticleId IdType="pubmed">22078110</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang M., Roh J.H., Jang H.K. Protective efficacy of a bivalent live attenuated vaccine against duck hepatitis A virus types 1 and 3 in ducklings. Vet Microbiol. 2018;214:108â112.</Citation><ArticleIdList><ArticleId IdType="pubmed">29408021</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang M.S., Jang H., Kim M.C., Kim M.J., Joh S.J., Kwon J.H., Kwon Y.K. Development of a stabilizer for lyophilization of an attenuated duck viral hepatitis vaccine. Poult Sci. 2010;89:1167â1170.</Citation><ArticleIdList><ArticleId IdType="pubmed">20460663</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley L.A., Mezulis S., Yates C.M., Wass M.N., Sternberg M.J. The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc. 2015;10:845â858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5298202</ArticleId><ArticleId IdType="pubmed">25950237</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M.C., Kwon Y.K., Joh S.J., Kim S.J., Tolf C., Kim J.H., Sung H.W., Lindberg A.M., Kwon J.H. Recent Korean isolates of duck hepatitis virus reveal the presence of a new geno- and serotype when compared to duck hepatitis virus type 1 type strains. Arch Virol. 2007;152:2059â2072.</Citation><ArticleIdList><ArticleId IdType="pubmed">17701025</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M.C., Kim M.J., Kwon Y.K., Lindberg A.M., Joh S.J., Kwon H.M., Lee Y.J., Kwon J.H. Development of duck hepatitis A virus type 3 vaccine and its use to protect ducklings against infections. Vaccine. 2009;27:6688â6694.</Citation><ArticleIdList><ArticleId IdType="pubmed">19747575</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolaskar A.S., Tongaonkar P.C. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 1990;276:172â174.</Citation><ArticleIdList><ArticleId IdType="pubmed">1702393</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou X.M., Mao S., Dong J.W., Chen J.Y., Sun D., Wang M.S., Zhu D.K., Jia R.Y., Chen S., Liu M.F., Yang Q., Wu Y., Zhao X.X., Zhang S.Q., Huang J., Gao Q., Liu Y.Y., Zhang L., Miao Z.J., Li Y.L., Li Y., Pan Q.W., Cheng A.C. A proposed disease classification system for duck viral hepatitis. Poult Sci. 2022;101</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9334327</ArticleId><ArticleId IdType="pubmed">35905549</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco J.M., Gladue D.P., Holinka L.G., Arzt J., Bishop E., Smoliga G., Pauszek S.J., Bracht A.J., O'Donnell V., Fernandez-Sainz I., Fletcher P., Piccone M.E., Rodriguez L.L., Borca M.V. A partial deletion in non-structural protein 3A can attenuate foot-and-mouth disease virus in cattle. Virology. 2013;446:260â267.</Citation><ArticleIdList><ArticleId IdType="pubmed">24074589</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai D.K., Diaz-San S.F., Campagnola G., Keith A., Schafer E.A., Kloc A., Santos D.L., Peersen O., Rieder E. Attenuation of foot-and-mouth disease virus by engineered viral polymerase fidelity. J Virol. 2017;91</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5651715</ArticleId><ArticleId IdType="pubmed">28515297</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajendran R., Srinivasan J., Natarajan J., Govindan K., Kumaragurubaran K., Muthukrishnan M., Seeralan M., Subbiah M., Sundaram R.S., Rao P.L., Ramasamy S. First report of duck hepatitis A virus genotype 2 in India. Vet Res Commun. 2023;47:1231â1241.</Citation><ArticleIdList><ArticleId IdType="pubmed">36595200</ArticleId></ArticleIdList></Reference><Reference><Citation>Roh J.H., Kang M. Live attenuated duck hepatitis virus vaccine in breeder ducks: Protective efficacy and kinetics of maternally derived antibodies. Vet Microbiol. 2018;219:107â112.</Citation><ArticleIdList><ArticleId IdType="pubmed">29778181</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S.H., Cheng L.F., Fu G.H., Chen H.M., Chen Z., Yang W.X., Su J.L., Huang Yu Y. Genome sequence analysis of the new serotype of duck hepatitis virus. J Microbiol. 2009;49:309â315.</Citation><ArticleIdList><ArticleId IdType="pubmed">19623953</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S.S., Li P.F., Zhang R.H., Chen J.H., Lan J.J., Lin S.L., Guo G.J., Xie Z.J., Jiang S.J. Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis A virus type 3 induces mucosal and systemic immune responses. Vaccine. 2019;37:4364â4369.</Citation><ArticleIdList><ArticleId IdType="pubmed">31227355</ArticleId></ArticleIdList></Reference><Reference><Citation>Su J.L., Huang Y., He R.L., Zhao J.X., Guo Y.P. Isolation and preliminary identification of a novel duck hepatitis virus. China Vet. Sci. Tech. 2002;32:15â16.</Citation></Reference><Reference><Citation>Sun Q.G., Xue S., Xiao A.F., Ma H.H., Zhu W., Qi S.H., Wen W.S., Shu Y.H., Xie H.L., Su J.L. Establishment and preliminary application of real-time RT-PCR detection for serotype 3 duck hepatitis A virus. Chi. J. Vet. Med. 2019;47:1â5.</Citation></Reference><Reference><Citation>Tauraso N.M., Coghill G.E., Klutch M.J. Properties of the attenuated vaccine strain of duck hepatitis virus. Avian Dis. 1969;13:321â329.</Citation><ArticleIdList><ArticleId IdType="pubmed">5796731</ArticleId></ArticleIdList></Reference><Reference><Citation>Tedeschi V., Purcell R.H., Emerson S.U. Partial characterization of hepatitis A viruses from three intermediate passage levels of a series resulting in adaptation to growth in cell culture and attenuation of virulence. J. Med. Virol. 1993;39:16â22.</Citation><ArticleIdList><ArticleId IdType="pubmed">8380839</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd D., Smyth V.J., Ball N.W., Donnelly B.M., Wylie M., Knowles N.J., Adair B.M. Identification of chicken enterovirus-like viruses, duck hepatitis virus type 2 and duck hepatitis virus type 3 as astroviruses. Avian Pathol. 2009;38:21â29.</Citation><ArticleIdList><ArticleId IdType="pubmed">19156577</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng C.H., Tsai H.J. Molecular characterization of a new serotype of duck hepatitis virus. Virus Res. 2007;126:19â31.</Citation><ArticleIdList><ArticleId IdType="pubmed">17292992</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F.C., Liu P., Li X.H., Liu R., Gao L., Cui H.Y., Zhang Y.P., Liu C.J., Qi X.L., Pan Q., Liu A.J., Wang X.M., Gao Y.L., Li K. Recombinant duck enteritis virus-vectored bivalent vaccine effectively protects against duck hepatitis A virus infection in ducks. Front. Microbiol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727602</ArticleId><ArticleId IdType="pubmed">35003046</ArticleId></ArticleIdList></Reference><Reference><Citation>Yehia N., Erfan A.M., Omar S.E., Soliman M.A. Dual circulation of duck hepatitis A virus genotypes 1 and 3 in Egypt. Avian Dis. 2021;65:1â9.</Citation><ArticleIdList><ArticleId IdType="pubmed">34339115</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh M.T., Bujaki E., Dolan P.T., Smith M., Wahid R., Konz J., Weiner A.J., Bandyopadhyay Van Damme P., De Coster I., Revets H., Macadam A., Andino R. Engineering the live-attenuated polio vaccine to prevent reversion to virulence. cell host microbe. 2020;27:736â751.e8. A. S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7566161</ArticleId><ArticleId IdType="pubmed">32330425</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh M.T., Capponi S., Catching A., Bianco S., Andino R. Mapping attenuation determinants in Enterovirus-D68. Viruses. 2020;12:867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7472100</ArticleId><ArticleId IdType="pubmed">32784424</ArticleId></ArticleIdList></Reference><Reference><Citation>Youn H.N., Noh J.Y., Kim M.S., Ju H.S., Park D.H., Lee D.Y., Kim K.J., Go S.H., Song C.S. Efficacy of a novel avian metapneumovirus live vaccine candidate based on vaccination route and age. Poult. Sci. 2021;100</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7936137</ArticleId><ArticleId IdType="pubmed">33518307</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan T.G., Wang H.W., Li C., Yang D.C., Zhou G.H., Yu L. T135I substitution in the nonstructural protein 2C enhances foot-and-mouth disease virus replication. Virus Genes. 2017;53:840â847.</Citation><ArticleIdList><ArticleId IdType="pubmed">28634750</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G.B., Hu B., Huo Y.Q., Lu J., Guo J., Deng M., Li P.F., Wang W.S., Li L., Meng S.L., Wang Z.J., Shen S. Amino acid substitutions in VP2, VP1, and 2C attenuate a Coxsackievirus A16 in mice. Microb Pathog. 2021;150</Citation><ArticleIdList><ArticleId IdType="pubmed">33271234</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R., Xia L., Chen J., Gong Y., Zhang L., Li P., Liu H., Xie Z., Jiang S. Molecular epidemiology and genetic diversity of duck hepatitis A virus type 3 in Shandong province of China, 2012-2014. Acta Virol. 2017;61:463â472.</Citation><ArticleIdList><ArticleId IdType="pubmed">29186963</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.Y., Wu S., Liu W.B., Hu Z.L. Current status and future direction of duck hepatitis A virus vaccines. Avian Pathol. 2023;52:89â99.</Citation><ArticleIdList><ArticleId IdType="pubmed">36571394</ArticleId></ArticleIdList></Reference><Reference><Citation>Van kuppeveld F.J., Melchers W.J., Kirkegaard K., Doedens J.R. Structure-function analysis of coxsackie B3 virus protein 2B. Virology. 1997;227:111â118.</Citation><ArticleIdList><ArticleId IdType="pubmed">9007064</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Pan W.S., Hu S.W., Zhai Z.H., Chen Y.N., Tang Z.L., Li Y.Z., Pan W.J., Shao S.Y., Chen Y.X., He M.Y., Cao Z., Liu S.Z. Research on Beijing duckling viral hepatitis (1) diagnosis and prevention. J. Peking Univ. Nat. Sci. 1980;7:55â74.</Citation></Reference><Reference><Citation>Wang Q.Q., Meng H.L., Ge D., Shan H., Geri L., Liu F. Structural and nonstructural proteins of Senecavirus A: Recent research advances, and lessons learned from those of other picornaviruses. Virology. 2023;585:155â163.</Citation><ArticleIdList><ArticleId IdType="pubmed">37348144</ArticleId></ArticleIdList></Reference><Reference><Citation>Weilandt R., Paulmann D., Schlottau K., Vallbracht A., Dotzauer A. Mutational modifications of hepatitis A virus proteins 2B and 2C described for cell culture-adapted and attenuated virus are present in wild-type virus populations. Arch. Virol. 2014;159:2699â2704.</Citation><ArticleIdList><ArticleId IdType="pubmed">24796555</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen H.Q., Han L.X., Zhang X.N., Lian C.J., Zhao L.L., Si C.D., Chen H.Y. Duck hepatitis A virus (DHAV) genotype definition: comment on the article by Cha et al. Vet. Microbiol. 2014;170:462â464.</Citation><ArticleIdList><ArticleId IdType="pubmed">24636163</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X., Zhu D., Cheng A., Wang M., Chen S., Jia R., Liu M., Sun K., Zhao X., Yang Q., Wu Y., Chen X. Molecular epidemiology of duck hepatitis a virus types 1 and 3 in China, 2010-2015. Transbound. Emerg. Dis. 2018;65:10â15.</Citation><ArticleIdList><ArticleId IdType="pubmed">29076646</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X.J., Guo J.L., Sun D., Wang M.S., Cao D., Cheng A.C., Zhu D.K., Liu M.F., Zhao X.X., Yang Q., Chen S., Jia R.Y., Wu Y., Zhang S.Q., Mao S., Ou X.M., Chen X.Y., Yu Y.L., Zhang L., Liu Y.Y., Tian B., Pan L.C., Rehman M.U. Mutations in VP0 and 2C proteins of duck hepatitis A virus type 3 attenuate viral infection and virulence. Vaccines (Basel) 2019;7:111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6789628</ArticleId><ArticleId IdType="pubmed">31514454</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X.J., Sun D., Guo J.L., Elgner F., Wang M.S., Hildt E., Cheng A.C. Multifunctionality of structural proteins in the enterovirus life cycle. Future Microbiol. 2019;14:1147â1157.</Citation><ArticleIdList><ArticleId IdType="pubmed">31368347</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolcock P.R. In: Diseases of poultry. 12th edn. Saif Y.M., Fadly A.M., Glisson J.R., McDougald L.R., Nolan L.K., Swayne D.E., editors. Iowa State Press; Ames: 2003. Duck hepatitis; pp. 343â354.</Citation></Reference><Reference><Citation>Wu F.Y., Lu F.Y., Fan X., Pan Q.X., Zhao S.Z., Sun H.W., Zhang J.F., Liu C.M., Chao J., Zhang X.F. Development of a live attenuated duck hepatitis A virus type 3 vaccine (strain SD70) Vaccine. 2020;38:4695â4703.</Citation><ArticleIdList><ArticleId IdType="pubmed">32446833</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>